Analyzing...
| # | Symbol | Name | MCap | ROE | ROCE | Growth 3yr | D/E | Margin |
|---|---|---|---|---|---|---|---|---|
| 1 | SUNPHARMA | Sun Pharmaceutical Industries Ltd | ₹4.41 Lakh Cr | 14.0% | 18.8% | 11.3% | 0.06x | 18.5% |
| 2 | DIVISLAB | Divi's Laboratories Ltd | ₹1.76 Lakh Cr | 16.1% | 20.1% | 2.3% | 0.01x | 23.1% |
| 3 | TORNTPHARM | Torrent Pharmaceuticals Ltd | ₹1.52 Lakh Cr | 26.9% | 29.0% | 6.1% | 0.31x | 18.0% |
| 4 | CIPLA | Cipla Ltd | ₹1.15 Lakh Cr | 13.8% | 17.9% | 8.8% | 0.00x | 15.5% |
| 5 | DRREDDY | Dr Reddy's Laboratories Ltd | ₹1.09 Lakh Cr | 15.5% | 19.1% | 15.3% | 0.12x | 15.4% |
| 6 | LUPIN | Lupin Ltd | ₹1.03 Lakh Cr | 23.7% | 27.5% | 11.5% | 0.29x | 17.5% |
| 7 | ZYDUSLIFE | Zydus Lifesciences Ltd | ₹1.02 Lakh Cr | 15.2% | 18.8% | 14.9% | 0.38x | 14.5% |
| 8 | MANKIND | Mankind Pharma Ltd | ₹1.02 Lakh Cr | 11.6% | 13.2% | - | 0.55x | 12.3% |
| 9 | AUROPHARMA | Aurobindo Pharma Ltd | ₹89,995 Cr | 10.0% | 15.1% | 10.8% | 0.21x | 10.3% |
| 10 | LAURUSLABS | Laurus Labs Ltd | ₹72,611 Cr | 17.5% | 21.1% | -2.4% | 0.45x | 12.4% |
| 11 | BIOCON | Biocon Ltd | ₹69,675 Cr | 2.3% | 3.6% | 25.2% | 0.59x | 3.5% |
| 12 | ALKEM | Alkem Laboratories Ltd | ₹63,190 Cr | 17.8% | 19.3% | 7.6% | 0.15x | 16.0% |
| 13 | GLENMARK | Glenmark Pharmaceuticals Ltd | ₹60,645 Cr | 11.1% | 15.3% | 2.5% | 0.09x | 6.4% |
| 14 | ABBOTINDIA | Abbott India Ltd | ₹57,054 Cr | 38.0% | 48.0% | - | 0.00x | 21.4% |
| 15 | ANTHEM | Anthem Biosciences Ltd | ₹43,778 Cr | - | - | - | — | - |
| 16 | GLAXO | GlaxoSmithKline Pharmaceuticals Ltd | ₹40,452 Cr | 59.8% | 70.0% | 5.1% | 0.00x | 25.8% |
| 17 | IPCALAB | IPCA Laboratories Ltd | ₹37,929 Cr | 12.3% | 14.1% | 15.3% | 0.16x | 9.5% |
| 18 | AJANTPHARM | Ajanta Pharma Ltd | ₹37,893 Cr | 23.5% | 29.3% | 11.1% | 0.05x | 19.0% |
| 19 | GLAND | Gland Pharma Ltd | ₹36,841 Cr | 8.9% | 12.7% | 8.0% | 0.03x | 13.3% |
| 20 | JBCHEPHARM | JB Chemicals & Pharmaceuticals Ltd | ₹35,100 Cr | 19.8% | 25.2% | 17.1% | 0.00x | 17.7% |